Immediate Impact
1 by Nobel laureates 2 from Science/Nature 55 standout
Citing Papers
Direct radical functionalization of native sugars
2024 StandoutNature
Mechanisms of long COVID and the path toward therapeutics
2024 Standout
Works of Andrzej Potemkowski being referenced
Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Andrzej Potemkowski | 155 | 81 | 29 | 91 | 33 | 421 | |
| Paola Basilico | 131 | 126 | 36 | 63 | 37 | 474 | |
| L.A. Liversedge | 183 | 129 | 36 | 52 | 37 | 479 | |
| B. Wanscher | 267 | 169 | 31 | 35 | 20 | 485 | |
| Monika Hofer | 154 | 153 | 17 | 158 | 42 | 504 | |
| Lucía Ayuso‐Peralta | 173 | 205 | 54 | 101 | 32 | 462 | |
| Jeffrey Palmer | 299 | 104 | 129 | 74 | 28 | 483 | |
| Fereshteh Ashtari | 324 | 229 | 27 | 38 | 49 | 467 | |
| Motohiro Kano | 48 | 47 | 19 | 104 | 28 | 458 | |
| Dolly Ann Padovani-Claudio | 103 | 17 | 62 | 86 | 16 | 392 | |
| Uroš Rot | 213 | 137 | 41 | 77 | 30 | 506 |
All Works
Login with ORCID to disown or claim papers
Loading papers...